Changes in serum lipids and lipoproteins in cancer patients during chemotherapy.

PubWeight™: 0.95‹?› | Rank: Top 15%

🔗 View Article (PMID 1505080)

Published in Cancer Chemother Pharmacol on January 01, 1992

Authors

C G Alexopoulos1, S Pournaras, M Vaslamatzis, A Avgerinos, S Raptis

Author Affiliations

1: Department of Medical Oncology, Evangelismos Hospital, Athens, Greece.

Articles by these authors

Outbreak of infections caused by Pseudomonas aeruginosa producing VIM-1 carbapenemase in Greece. J Clin Microbiol (2000) 4.67

Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issues. Clin Microbiol Infect (2010) 4.07

Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment. Clin Microbiol Infect (2011) 2.92

Carbapenem-hydrolysing VIM-2 metallo- beta-lactamase in Pseudomonas aeruginosa from Greece. J Antimicrob Chemother (2000) 2.29

Reversibility of unawareness of hypoglycemia in patients with insulinomas. N Engl J Med (1993) 1.83

Intestinal decontamination improves liver haemodynamics in patients with alcohol-related decompensated cirrhosis. Aliment Pharmacol Ther (2009) 1.74

Long-term results of femorotibial bypass with vein or polytetrafluoroethylene. Br J Surg (1998) 1.69

Early administration of somatostatin and efficacy of sclerotherapy in acute oesophageal variceal bleeds: the European Acute Bleeding Oesophageal Variceal Episodes (ABOVE) randomised trial. Lancet (1997) 1.68

Serum lipids and lipoprotein disorders in cancer patients. Cancer (1987) 1.28

Heteroresistance to carbapenems in Acinetobacter baumannii. J Antimicrob Chemother (2005) 1.17

ICCE consensus for bowel preparation and prokinetics. Endoscopy (2005) 1.15

Effects of somatostatin on exocrine and endocrine pancreatic function stimulated by intestinal hormones in man. Horm Metab Res (1976) 1.14

Massive hemothorax due to intrathoracic extramedullary hematopoiesis in a patient with hereditary spherocytosis. Ann Hematol (2001) 1.12

A review of the management of 100 cases of benign stricture of the oesophagus. Thorax (1972) 1.12

Relationship of Helicobacter pylori CagA status to gastric cell proliferation and apoptosis. Dig Dis Sci (1999) 1.12

Persistent colonization of nine cystic fibrosis patients with an Achromobacter (Alcaligenes) xylosoxidans clone. Eur J Clin Microbiol Infect Dis (2004) 1.12

Effects of somatostatin on the exocrine pancreas and the release of duodenal hormones. Metabolism (1978) 1.11

Clusters of imipenem-resistant Acinetobacter baumannii clones producing different carbapenemases in an intensive care unit. Clin Microbiol Infect (2008) 1.11

Propranolol in the prevention of recurrent upper gastrointestinal bleeding in patients with cirrhosis undergoing endoscopic sclerotherapy. A randomized controlled trial. J Hepatol (1993) 1.10

Hypergastrinemia induced by glucocorticoid and corticotropin treatment in man. Am J Dig Dis (1976) 1.09

Evaluation of high-risk human papillomavirus types PCR detection in paired urine and cervical samples of women with abnormal cytology. J Clin Virol (2006) 1.09

Concentrations of prostaglandin A-, E- and F-like substances in gastric mucosa of normal subjects and of patients with various gastric diseases. Clin Sci Mol Med (1977) 1.07

Effects of somatostatin on gastric secretion and gastrin release in man. Digestion (1975) 1.05

Once-daily insulin glargine administration in the morning compared to bedtime in combination with morning glimepiride in patients with type 2 diabetes: an assessment of treatment flexibility. Horm Metab Res (2006) 1.05

Gastrin concentration in plasma of the neonate at birth and after the first feeding. Pediatrics (1976) 1.04

Prevalence of hepatitis B virus marker positivity and evolution of hepatitis B virus profile, during chemotherapy, in patients with solid tumours. Br J Cancer (1999) 1.03

Investigations on the penetration of ranitidine into the cerebrospinal fluid and a comparison of the effects of ranitidine and cimetidine on male sex hormones. Scand J Gastroenterol Suppl (1981) 1.02

Methicillin-resistant Staphylococcus aureus in the hospitals of central Greece. Int J Antimicrob Agents (2001) 1.01

Correlation of bone mineral density with the histological findings of renal osteodystrophy in patients on hemodialysis. J Nephrol (2000) 1.00

Monoclonal gammopathies in B-cell non-Hodgkin's lymphomas. Leuk Res (2003) 0.99

Endoscopic ultrasonography in the diagnosis and management of portal hypertension. Where are we next? Dig Liver Dis (2006) 0.99

The value of a single combined measurement of VEGF, glycodelin, progesterone, PAPP-A, HPL and LIF for differentiating between ectopic and abnormal intrauterine pregnancy. Hum Reprod (2005) 0.98

Arterial injury in the lower limb from blunt trauma. Aust N Z J Surg (1997) 0.97

The effect of a pure antiandrogen receptor blocker, flutamide, on the lipid profile in the polycystic ovary syndrome. J Clin Endocrinol Metab (1998) 0.95

Anterior, posterior, or laparoscopic approach for the management of adrenal diseases? Am J Surg (1997) 0.95

Specific signals generated by the cytoplasmic domain of the granulocyte colony-stimulating factor (G-CSF) receptor are not required for G-CSF-dependent granulocytic differentiation. Blood (1998) 0.94

Spread of low-level carbapenem-resistant Acinetobacter baumannii clones in a tertiary care Greek hospital. J Antimicrob Chemother (2003) 0.94

Metastatic liver disease of colorectal origin: the value of locoregional immunochemotherapy combined with systemic chemotherapy following liver resection. Results of a prospective randomized study. Hepatogastroenterology (2002) 0.94

Absorption of iodized contrast media during ERCP. Gastrointest Endosc (1986) 0.94

Somatostatin not helpful in bleeding esophageal varices. N Engl J Med (1979) 0.94

A prospective randomized trial comparing somatostatin, balloon tamponade and the combination of both methods in the management of acute variceal haemorrhage. J Hepatol (1991) 0.92

Endoscopic sclerotherapy versus variceal ligation in the long-term management of patients with cirrhosis after variceal bleeding. A prospective randomized study. J Hepatol (1997) 0.92

Immune abnormalities in myelodysplastic syndromes. J Clin Pathol (1985) 0.92

VIM-2 metallo-beta-lactamase in Achromobacter xylosoxidans in Europe. Eur J Clin Microbiol Infect Dis (2005) 0.91

Effects of cardioselective and non-cardioselective beta-blockade on adrenaline-induced metabolic and cardiovascular responses in man. Eur J Clin Pharmacol (1981) 0.91

Potentially explosive colonic concentrations of hydrogen after bowel preparation with mannitol. Lancet (1981) 0.91

Bowel preparation and the risk of explosion during colonoscopic polypectomy. Gut (1984) 0.91

Predicting outcome in ruptured abdominal aortic aneurysm: a prospective study of 100 consecutive cases. Eur J Vasc Endovasc Surg (2003) 0.91

Insulin sensitivity and antiandrogenic therapy in women with polycystic ovary syndrome. Metabolism (1995) 0.91

Trends in antimicrobial resistance of clinical isolates of Enterococcus faecalis and Enterococcus faecium in Greece between 2002 and 2007. J Hosp Infect (2010) 0.89

New frontiers in liver surgery. Two-stage liver surgery for the management of advanced metastatic liver disease. Hepatogastroenterology (1999) 0.89

The role of the exocrine pancreas in the stimulation of insulin secretion by intestinal hormones. I. The effect of pancreozymin, secretin, gastrin-pentapeptide and of glucagon upon insulin secretion of isolated islets of rat pancreas. Diabetologia (1971) 0.89

Existing delays following the presentation of ruptured abdominal aortic aneurysm allow sufficient time to assess patients for endovascular repair. Eur J Vasc Endovasc Surg (2005) 0.88

Cold agglutinin disease in non-Hodgkin's lymphoma. Eur J Haematol (1995) 0.88

Predominance of a methicillin-resistant Staphylococcus aureus clone susceptible to erythromycin and several other non-beta-lactam antibiotics in a Greek hospital. J Antimicrob Chemother (2001) 0.88

'Trash foot' following operations involving the abdominal aorta. Aust N Z J Surg (1997) 0.88

Insulin therapy in relation to circulating C-peptide levels. Diabetes (1978) 0.88

Somatostatin: a potent inhibitor of ACTH-hypersecretion in adrenal insufficiency. Klin Wochenschr (1976) 0.87

Substantially increased faecal carriage of vancomycin-resistant enterococci in a tertiary Greek hospital after a 4 year time interval. J Antimicrob Chemother (2004) 0.86

Preferential involvement of 11q23-24 and 11p15 in breast cancer. Cancer Genet Cytogenet (1991) 0.86

Cytogenetic study in multiple myeloma. Cancer Genet Cytogenet (1984) 0.86

Apparent increased prevalence of high-level aminoglycoside-resistant Enterococcus durans resulting from false identification by a semiautomated software system. J Clin Microbiol (1998) 0.85

Biosynthetic human insulin: progress and prospects. Diabetes Care (1981) 0.85

Inhibition of cholecystokinin-pancreozymin release by somatostatin. Lancet (1977) 0.85

Somatostatin and its analogues in peptic ulcer bleeding: facts and pathophysiological aspects. Dig Liver Dis (2005) 0.85

Invasive balantidiasis presented as chronic colitis and lung involvement. Dig Dis Sci (1989) 0.85

Inhibition of TSH-stimulated radioiodine turnover and release of T4 and T3 in vivo by somatostatin. Metabolism (1978) 0.85

A reliable method for generating antibodies against pancreozymin, secretin and gastrin. Clin Chim Acta (1976) 0.84

Evaluation and comparison of fluorescence polarization assay with three of the currently used serological tests in diagnosis of human brucellosis. Eur J Clin Microbiol Infect Dis (2007) 0.84

The role of the exocrine pancreas in the stimulation of insulin secretion by intestinal hormones. 3. Insulin responses to secretin and pancreozymin, and to oral and intravenous glucose, in patients suffering from chronic insufficiency of the exocrine pancreas. Diabetologia (1971) 0.84

Effect of somatostatin on bile-induced acute hemorrhagic pancreatitis in the dog. Horm Metab Res (1979) 0.84

Soft-tissue abscess involving Actinomyces odontolyticus and two Prevotella species in an intravenous drug abuser. Comp Immunol Microbiol Infect Dis (2004) 0.84

Pseudo-outbreak of imipenem-resistant Acinetobacter baumannii resulting from false susceptibility testing by a rapid automated system. J Clin Microbiol (2000) 0.84

Progression toward malignancy of hamartomas in a patient with Peutz-Jeghers syndrome: case report and literature review. Can J Surg (1994) 0.84

A phase II study of the effectiveness of docetaxel (Taxotere) in women with advanced breast cancer previously treated with polychemotherapy. Hellenic Cooperative Interhospital Group in Oncology. Cancer Chemother Pharmacol (1999) 0.84

Upper extremity arterial injuries: experience at the Royal Adelaide Hospital, 1969 to 1991. J Vasc Surg (1994) 0.84

Effect of the proton motive force inhibitor carbonyl cyanide-m-chlorophenylhydrazone (CCCP) on Pseudomonas aeruginosa biofilm development. Lett Appl Microbiol (2008) 0.84

Primary extranodal non-Hodgkin's lymphoma in adults: clinicopathological and survival characteristics. Leuk Lymphoma (1996) 0.83

The Bcl-2/Bax system and apoptosis in ulcerative colitis. Hepatogastroenterology (2007) 0.83

Codon 12 ras mutations in patients with myelodysplastic syndrome: incidence and prognostic value. Ann Hematol (1997) 0.83

Primary gastric lymphoma--the experience of a general hospital. Br J Cancer (1985) 0.83

Effects of secretin and cholecystokinin on motor activity of human jejunum. A radiotelemetering study of jejunal motility during secretin and cholecystokinin intravenous infusion. Digestion (1975) 0.83

Effect of polyethylene glycol electrolyte balanced solution on patients with acute colonic pseudo obstruction after resolution of colonic dilation: a prospective, randomised, placebo controlled trial. Gut (2005) 0.83

Docetaxel and granulocyte colony-stimulating factor in patients with advanced non-small-cell lung cancer previously treated with platinum-based chemotherapy: a multicenter phase II trial. Cancer Chemother Pharmacol (1999) 0.83

Trends in the presentation and surgical management of the acute diabetic foot. Eur J Vasc Endovasc Surg (2005) 0.82

Primary secretion of insulin and secondary release of glucagon from the isolated perfused rat pancreas following stimulation with pancreozymin. Horm Metab Res (1969) 0.82

Characteristics, cardiovascular comorbidity and medicines management in patients with type 2 diabetes and CKD: results of the IRIDIEM study. Kidney Blood Press Res (2010) 0.82

Paraplegia in a pregnant thalassemic woman due to extramedullary hematopoiesis: successful management with transfusions. Surg Neurol (1991) 0.82

Identification of a novel bla(OXA-51) variant, bla(OXA-92), from a clinical isolate of Acinetobacter baumannii. Clin Microbiol Infect (2007) 0.82

Atypical location of extramedullary hematopoietic masses in thalassemia. Radiologe (1989) 0.82

Diffuse pulmonary carcinomatous embolization: a rare and fatal manifestation of ovarian cancer. Gynecol Oncol (1991) 0.82

Use of real-time PCR to detect human papillomavirus-16 viral loads in vaginal and urine self-sampled specimens. Clin Microbiol Infect (2008) 0.82

Sero epidemiology of Bordetella pertussis immune responses in a healthy population in northern Greece. J Clin Lab Anal (2004) 0.82

Care and outcomes in patients with ischemic stroke with and without preexisting dementia. Neurology (2011) 0.81

Low genetic diversity of the intrinsic OXA-51-like class D carbapenemases among Acinetobacter baumannii clinical isolates in Greece. Epidemiol Infect (2006) 0.81

Consecutive re-explorations for final resection of initially unresectable pancreatic head carcinoma. Hepatogastroenterology (1999) 0.81

Multiresistant Acinetobacter baumannii isolates in intensive care units in Greece. Clin Microbiol Infect (2003) 0.81

Evaluation of HPV 16 PCR detection in self- compared with clinician-collected samples in women referred for colposcopy. Gynecol Oncol (2006) 0.81